ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 331 filers reported holding ROYALTY PHARMA PLC in Q4 2022. The put-call ratio across all filers is 0.58 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,447,024 | +1.6% | 90,163 | +15.1% | 0.09% | -1.1% |
| Q2 2023 | $2,407,557 | -18.6% | 78,320 | +4.6% | 0.09% | -48.9% |
| Q4 2022 | $2,959,258 | -45.1% | 74,880 | -45.8% | 0.18% | -15.6% |
| Q1 2022 | $5,387,000 | +109.9% | 138,281 | +114.7% | 0.21% | +83.5% |
| Q4 2021 | $2,567,000 | +62.4% | 64,411 | +47.2% | 0.12% | +27.8% |
| Q3 2021 | $1,581,000 | -66.4% | 43,749 | -61.8% | 0.09% | -70.2% |
| Q2 2021 | $4,700,000 | +58.6% | 114,669 | +68.8% | 0.30% | +105.4% |
| Q1 2021 | $2,963,000 | – | 67,930 | – | 0.15% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SIGULER GUFF ADVISERS, LLC | 6,761,970 | $338,436,000 | 92.73% |
| Vantage Consulting Group Inc | 21,477,282 | $1,074,938,000 | 87.53% |
| Memorial Sloan Kettering Cancer Center | 3,565,887 | $178,473,000 | 75.56% |
| HARVARD MANAGEMENT CO INC | 14,690,780 | $735,274,000 | 39.88% |
| ROBERT WOOD JOHNSON FOUNDATION | 3,958,498 | $1,981,228,000 | 21.69% |
| Brown University | 381,759 | $19,107,000 | 13.82% |
| Overbrook Management Corp | 778,511 | $38,964,000 | 9.50% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 38,714,280 | $1,937,650,000 | 4.22% |
| Lagoda Investment Management, L.P. | 96,885 | $4,849,000 | 2.61% |
| HealthCor Management, L.P. | 1,339,530 | $67,043,000 | 2.58% |